In the current issue of Psychotherapy and Psychosomatics a meta-analysis is performed on the cardiovascular risk of antidepressant drugs.Antidepressants are commonly prescribed medications, but their long-term health effects are debated. Antidepressants disrupt multiple adaptive processes regulated by evolutionarily ancient biochemicals, potentially increasing mortality. However, many antidepressants also have anticlotting properties that can be efficacious in treating cardiovascular disease.
Autumn is flu season and that means it is high season for pharmacies selling over-the-counter cold and flu remedies. Those who aren’t reminded by their own running noses, are sure to be alerted to these types of pharmaceutical drugs by advertisements and posters. A team of researchers has recently studied the extent to which pharmaceutical advertising supports the so-called self-empowerment of patients. The investigation focused on Brazil, the fastest-growing pharmaceutical drug market in the world.
A new study reveals that due to a lack of specific recommendations for medication use during pregnancy, many pregnant women search the Internet for information.
Stroke patients who stopped taking statin drugs three to six months after a first ischemic stroke, the type caused by narrowed arteries, had a higher risk of a having another stroke within a year, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Authors conclude that proton-pump inhibitors should be co-prescribed in this age group to reduce the risk of bleeds.
A new analysis suggests that among older adults who take cardiovascular medications, those using non-selective beta-blockers may be at an increased of falling compared with those using selective beta-blockers. These types of drugs are already known to differ by their receptor binding properties and their systemic effects on the body.